PGEN
Price
$1.54
Change
+$0.02 (+1.32%)
Updated
Feb 29, 6:59 PM EST
69 days until earnings call
VERV
Price
$17.05
Change
-$0.91 (-5.07%)
Updated
Feb 29, 6:59 PM EST
67 days until earnings call
Ad is loading...

Analysis and predictions PGEN vs VERV

Header iconPGEN vs VERV Comparison
Open Charts PGEN vs VERVBanner chart's image
Precigen
Price$1.54
Change+$0.02 (+1.32%)
Volume$702.19K
CapitalizationN/A
Verve Therapeutics
Price$17.05
Change-$0.91 (-5.07%)
Volume$1.13M
CapitalizationN/A
View a ticker or compare two or three
PGEN vs VERV Comparison Chart

Loading...

PGENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VERVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
PGEN vs. VERV commentary
Mar 01, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGEN is a Buy and VERV is a Hold.

COMPARISON
Comparison
Mar 01, 2024
Stock price -- (PGEN: $1.54 vs. VERV: $17.05)
Brand notoriety: PGEN and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PGEN: 110% vs. VERV: 178%
Market capitalization -- PGEN: $383.34M vs. VERV: $1.43B
PGEN [@Biotechnology] is valued at $383.34M. VERV’s [@Biotechnology] market capitalization is $1.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $541.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PGEN’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • PGEN’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, PGEN is a better buy in the long-term than VERV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PGEN’s TA Score shows that 5 TA indicator(s) are bullish while VERV’s TA Score has 5 bullish TA indicator(s).

  • PGEN’s TA Score: 5 bullish, 4 bearish.
  • VERV’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PGEN is a better buy in the short-term than VERV.

Price Growth

PGEN (@Biotechnology) experienced а +6.94% price change this week, while VERV (@Biotechnology) price change was +28.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.64%. For the same industry, the average monthly price growth was +16.56%, and the average quarterly price growth was +43.85%.

Reported Earning Dates

PGEN is expected to report earnings on May 09, 2024.

VERV is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+5.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for PGEN with price predictions.
OPEN
A.I.dvisor published
a Summary for VERV with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VERV($1.43B) has a higher market cap than PGEN($383M). VERV YTD gains are higher at: 22.310 vs. PGEN (14.925). PGEN has higher annual earnings (EBITDA): -77.27M vs. VERV (-212.02M). VERV has more cash in the bank: 485M vs. PGEN (73.8M). PGEN has less debt than VERV: PGEN (7.39M) vs VERV (76.8M). VERV has higher revenues than PGEN: VERV (7.63M) vs PGEN (6.76M).
PGENVERVPGEN / VERV
Capitalization383M1.43B27%
EBITDA-77.27M-212.02M36%
Gain YTD14.92522.31067%
P/E RatioN/A3.16-
Revenue6.76M7.63M89%
Total Cash73.8M485M15%
Total Debt7.39M76.8M10%
TECHNICAL ANALYSIS
Technical Analysis
PGENVERV
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 25 days ago
84%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
PGENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VERVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TVIFX73.320.97
+1.34%
Thornburg Small/Mid Cap Core I
LGCRX15.110.07
+0.47%
Lord Abbett Global Equity R3
TPICX11.780.05
+0.43%
Timothy Plan International C
GATEX41.910.15
+0.36%
Gateway A
FDFAX92.39-0.13
-0.14%
Fidelity Select Consumer Staples Port

PGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PGEN has been loosely correlated with VERV. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PGEN jumps, then VERV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGEN
1D Price
Change %
PGEN100%
+1.32%
VERV - PGEN
52%
Loosely correlated
-5.07%
MDGL - PGEN
51%
Loosely correlated
-7.25%
NTLA - PGEN
49%
Loosely correlated
-2.07%
BEAM - PGEN
48%
Loosely correlated
-9.45%
ADPT - PGEN
44%
Loosely correlated
-0.96%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
-5.07%
BEAM - VERV
62%
Loosely correlated
-9.45%
CRSP - VERV
61%
Loosely correlated
-3.93%
NTLA - VERV
58%
Loosely correlated
-2.07%
PGEN - VERV
52%
Loosely correlated
+1.32%
MDGL - VERV
52%
Loosely correlated
-7.25%
More